Light AI (FRA:0HC) 1-Year Sharpe Ratio: 0.39 (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0HC Light AI Inc FRA:0HC
34 GF Score
Price €0.11
! 3 Warning Signs
View Full Analysis

What is Light AI 1-Year Sharpe Ratio?

Light AI FRA:0HC +26.44% 34 1-Year Sharpe Ratio is 0.39 as of Aug. 06, 2026. GuruFocus rates FRA:0HC with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-06), Light AI's 1-Year Sharpe Ratio is 0.39.


Light AI  (FRA:0HC) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Light AI 1-Year Sharpe Ratio Related Terms


FRA:0HC vs VEEV, BTSG, HQY: 1-Year Sharpe Ratio Comparison

For the Health Information Services subindustry, Light AI's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Light AI 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Light AI's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Light AI's 1-Year Sharpe Ratio falls into.


FRA:0HC
34GF Score
Light AI Inc FRA:0HC
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Light AI 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.39 mean?
Light AI (FRA:0HC) has a 1-Year Sharpe Ratio of 0.39 as of Aug. 06, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Light AI and its competitors.
Is Light AI's 1-Year Sharpe Ratio too high?
Light AI's current 1-Year Sharpe Ratio is 0.39. Overall, Light AI has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Light AI's 1-Year Sharpe Ratio compare to VEEV and BTSG?
Light AI's 1-Year Sharpe Ratio of 0.39 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Light AI and its competitors. Light AI's current 1-Year Sharpe Ratio is 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Light AI stock overvalued right now?
Light AI (FRA:0HC) has a current 1-Year Sharpe Ratio of 0.39. The current 1-Year Sharpe Ratio is 0.39. Light AI's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Light AI (FRA:0HC), the current 1-Year Sharpe Ratio is 0.39 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Light AI Business Description

Address 1055 West Georgia Street, Suite 1500, P.O. Box 11117, Vancouver, BC, CAN, V6E 4N7
Light AI Inc is currently focused on the development of healthcare solutions to combat disease and reduce the use and misuse of antibiotics. It is currently pre-revenue and therefore the Company's ability to continue as a going concern is dependent upon its ability to continue to obtain borrowings from third parties or raise capital, sufficient to meet current and future obligations and to complete development of its product.
34GF Score

Get the complete analysis for FRA:0HC

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price